X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5846) 5846
Publication (741) 741
Book Review (77) 77
Book Chapter (47) 47
Conference Proceeding (8) 8
Dissertation (8) 8
Book / eBook (3) 3
Government Document (3) 3
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3287) 3287
index medicus (3233) 3233
animals (1958) 1958
male (1953) 1953
female (1662) 1662
middle aged (1199) 1199
aged (850) 850
angiogenesis (826) 826
adult (822) 822
microcirculation (669) 669
analysis (665) 665
microvascular endothelial-cells (657) 657
rats (645) 645
risk factors (625) 625
microvascular complications (617) 617
peripheral vascular disease (616) 616
endothelium (614) 614
cardiac & cardiovascular systems (612) 612
mice (596) 596
diabetes (560) 560
endocrinology & metabolism (544) 544
expression (535) 535
cell biology (496) 496
article (468) 468
neurosciences (453) 453
cells, cultured (450) 450
research (446) 446
physiology (437) 437
hypertension (417) 417
microvascular density (415) 415
medicine & public health (407) 407
inflammation (397) 397
permeability (380) 380
oncology (357) 357
pharmacology & pharmacy (357) 357
microvasculature (335) 335
health aspects (331) 331
care and treatment (329) 329
oxidative stress (322) 322
cancer (320) 320
in-vivo (318) 318
blood-flow (316) 316
immunohistochemistry (314) 314
in-vitro (314) 314
physiological aspects (311) 311
endothelial growth-factor (306) 306
radiology, nuclear medicine & medical imaging (297) 297
type 2 diabetes (297) 297
atherosclerosis (296) 296
endothelial cells (295) 295
hematology (288) 288
time factors (287) 287
disease (286) 286
endothelial cells - metabolism (281) 281
apoptosis (280) 280
prognosis (277) 277
biochemistry & molecular biology (276) 276
microvascular permeability (275) 275
blood pressure (273) 273
medicine (271) 271
medicine, research & experimental (271) 271
microvascular dysfunction (270) 270
proteins (269) 269
cardiology (266) 266
diabetes mellitus (266) 266
surgery (264) 264
aged, 80 and over (263) 263
rats, sprague-dawley (259) 259
disease models, animal (256) 256
cardiovascular disease (254) 254
perfusion (253) 253
brain (252) 252
ischemia (252) 252
vascular endothelial growth factor (252) 252
blood-brain barrier (246) 246
nitric-oxide (240) 240
mortality (238) 238
diabetic retinopathy (237) 237
endothelial-cells (236) 236
cells (234) 234
blood-pressure (233) 233
studies (228) 228
ophthalmology (226) 226
cardiovascular-disease (224) 224
risk-factors (224) 224
activation (220) 220
risk (218) 218
rodents (218) 218
medical research (214) 214
microcirculation - physiology (212) 212
research article (212) 212
treatment outcome (211) 211
diagnosis (210) 210
mellitus (210) 210
glucose (205) 205
internal medicine (205) 205
pathology (204) 204
immunology (202) 202
diabetes mellitus, type 2 - complications (201) 201
tumors (197) 197
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5865) 5865
Spanish (15) 15
German (7) 7
Russian (4) 4
Chinese (2) 2
Czech (2) 2
French (2) 2
Japanese (2) 2
Korean (2) 2
Hungarian (1) 1
Persian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Phytotherapy Research, ISSN 0951-418X, 02/2019, Volume 33, Issue 2, pp. 294 - 308
Macrophage activation plays a central role in neoatherosclerosis and in‐stent restenosis after percutaneous coronary intervention (PCI). Galectin‐3, mainly... 
galectin‐3 | macrophage activation | rosuvastatin | berberine | galectin-3 | MICROVASCULAR OBSTRUCTION | CHEMISTRY, MEDICINAL | HEMORRHAGE | NO-REFLOW PHENOMENON | REPERFUSION | DUAL ANTIPLATELET THERAPY | NUCLEAR-FACTOR | INFLAMMATION | ACUTE MYOCARDIAL-INFARCTION | RESTENOSIS | PHARMACOLOGY & PHARMACY | DRUG-ELUTING STENTS | AMP-Activated Protein Kinases - metabolism | Humans | Middle Aged | Galectin 3 - metabolism | Male | NF-kappa B - metabolism | Inflammation - metabolism | Inflammation - drug therapy | Aged, 80 and over | Female | Lipoproteins, LDL - metabolism | Macrophages - physiology | Cells, Cultured | Down-Regulation - drug effects | Galectin 3 - genetics | Down-Regulation - genetics | Gene Expression Regulation - drug effects | Berberine - pharmacology | Signal Transduction - drug effects | Transcription Factor RelA - metabolism | Inflammation - genetics | Macrophages - drug effects | Aged | Macrophage Activation - drug effects | Percutaneous Coronary Intervention | Translocation | Lipoproteins (low density) | Berberine | Surgical implants | CD11b antigen | CD86 antigen | Cytokines | Confocal microscopy | Lipids | Activation | Inflammation | Macrophages | Patients | Density | Nuclear transport | Western blotting | Restenosis | Signal transduction | Signaling | Cell activation | Pathways | Microscopy | Implants | Inhibition
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2011, Volume 57, Issue 2, pp. 153 - 159
Objectives The purpose of this study was to determine the factors associated with the favorable effect of pioglitazone on atheroma progression. Background... 
atherosclerosis | diabetes | intravascular ultrasonography | INTIMA-MEDIA THICKNESS | MORTALITY | GLYCEMIC CONTROL | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | RANDOMIZED CONTROLLED-TRIAL | MICROVASCULAR COMPLICATIONS | MELLITUS | CARDIOVASCULAR-DISEASE | BLOOD-GLUCOSE CONTROL | TYPE-2 | Ultrasonography, Interventional - methods | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Thiazolidinediones - administration & dosage | Coronary Artery Disease - blood | Thiazolidinediones - therapeutic use | Atherosclerosis - diagnostic imaging | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus, Type 2 - complications | Coronary Stenosis - diagnostic imaging | Hypoglycemic Agents - therapeutic use | Coronary Stenosis - complications | Double-Blind Method | Cholesterol, HDL - drug effects | Atherosclerosis - complications | Disease Progression | Coronary Stenosis - blood | Atherosclerosis - blood | Coronary Artery Disease - diagnostic imaging | Diabetes Mellitus, Type 2 - blood | Coronary Artery Disease - complications | Triglycerides - blood | Cholesterol, HDL - blood | Diabetes Mellitus, Type 2 - drug therapy | Hypertension | Lipoproteins | Ultrasonic imaging | Heart attacks | Normal distribution | Atherosclerosis | Cardiovascular disease | Triglycerides | Diabetes | Glucose | Cholesterol
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 12/2015, Volume 30, Issue 12, pp. 2188 - 2199
Journal Article
Journal Article
by Xie, B and Wang, YY and He, JK and Ni, ZZ and Chai, DM
CANCER CONTROL, ISSN 1073-2748, 09/2019, Volume 26, Issue 1, p. 107327481987573
Cyclin E and hepatocyte growth factor (HGF) have been observed as a multifaceted factor in many cancers, and the assessment of microvascular density (MVD) and... 
cyclin E | micro-lymphatic vessel density | SURVIVAL | microvascular density | ONCOLOGY | hepatocyte growth factor | immunohistochemistry | AXIS
Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 2012, Volume 26, Issue 7, pp. 1085 - 1094
Highlight ► N -acetylcysteine protects against LPS-induced inhibition of amyloid beta efflux across the blood–brain barrier. 
Psychiatry | Allergy and Immunology | Oxidative stress | Amyloid beta | Alzheimer’s disease | Lipopolysaccharide | Pgp | Neuroinflammation | LRP-1 | N-acetylcysteine | Alzheimer's disease | P-GLYCOPROTEIN FUNCTION | METABOLIC SYNDROME | PSYCHIATRY | ALZHEIMERS-DISEASE | MICROVASCULAR ENDOTHELIAL-CELLS | COGNITIVE IMPAIRMENT | NECROSIS-FACTOR-ALPHA | IMMUNOLOGY | NEUROSCIENCES | SYSTEMIC INFLAMMATION | AMYLOID-BETA-PEPTIDE | ACETYL-L-CYSTEINE | Inflammation - chemically induced | Chemokines - blood | Glutathione - metabolism | Antioxidants - metabolism | Cerebral Cortex - pathology | Acetylcysteine - metabolism | Male | Protein Carbonylation - drug effects | Cerebral Cortex - metabolism | Lipopolysaccharides | Inflammation - metabolism | Amyloid beta-Peptides - metabolism | Calcium Channel Blockers - metabolism | Cytokines - blood | Tumor Suppressor Proteins - metabolism | Cytokines - metabolism | Receptors, LDL - metabolism | Hippocampus - pathology | Antioxidants - pharmacology | Blood-Brain Barrier - drug effects | Blood-Brain Barrier - metabolism | Hippocampus - metabolism | alpha-Macroglobulins - metabolism | Algorithms | Animals | Acetylcysteine - pharmacology | Chemokines - metabolism | Mice | Oxidative Stress - drug effects | Verapamil - metabolism | Inflammation - physiopathology | Serum Albumin - metabolism | Antioxidants | Acetylcysteine | Mitogens | Low density lipoproteins | neuroinflammation | lipopolysaccharide | oxidative stress
Journal Article
Biomaterials, ISSN 0142-9612, 07/2018, Volume 170, pp. 58 - 69
Journal Article